Article Information
History
- February 29, 2024.
Article Versions
- Version 1 (February 28, 2024 - 09:36).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Xia Wang1,2,
- Ho-Hyung Woo3,6,
- Michele Wei2,
- Steven Gibson3,6,
- Mitzi Miranda3,6,
- Demaretta Rush4,
- Janiel Cragun3,6,
- Wenxin Zheng5,
- Guang Yao2,6,* and
- Setsuko K Chambers3,6,*
- 1College of Animal Science and Technology, Northwest A&F University, Shaanxi, China
- 2Department of Molecular and Cellular Biology, University of Arizona, Tucson, AZ
- 3Department of Obstetrics and Gynecology, University of Arizona, Tucson, AZ
- 4Department of Pathology, University of Arizona, Tucson, AZ
- 5Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX
- 6University of Arizona Cancer Center, Tucson, AZ
- ↵*To whom correspondence may be addressed. email: guangyao{at}arizona.edu
Posted February 29, 2024.
Antiandrogen Flutamide-Induced Restoration of miR-449 Expression Mitigates Functional Biomarkers Associated with Ovarian Cancer Risk
